Acceleron Pharma reported $-19000000 in Operating Profit for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acceleron Pharma XLRN:US $ -19M 33M
Akebia Therapeutics AKBA:US $ -58.1M 115.72M
Alexion Pharmaceuticals ALXN:US $ -1370.2M 2065.7M
Amgen AMGN:US $ 2323M 32M
Bayer BAYN:GR -1078400000 1.33B
Biomarin Pharmaceutical BMRN:US $ -40.94M 145.91M
Bluebird Bio BLUE:US $ -25.94M 177.48M
Clovis Oncology CLVS:US $ -86M 4M
Dicerna Pharmaceuticals DRNA:US $ -22.9M 10.59M
Eli Lilly And LLY:US $ 1196.8M 394M
Exelixis EXEL:US $ 75M 23M
Gilead Sciences GILD:US $ -2983M 5385M
GlaxoSmithKline GSK:LN 285M 83.6M
Johnson & Johnson JNJ:US $ 4401M 461M
Neurocrine Biosciences NBIX:US $ 76M 18M
Novartis NOVN:VX 2.35B 392M
Pfizer PFE:US $ 3441M 1147M
Ptc Therapeutics PTCT:US $ -187.27M 94.28M
Puma Biotechnology PBYI:US $ 7M 22M
Regeneron Pharmaceuticals REGN:US $ 656.4M 43.7M
Ultragenyx Pharmaceutical RARE:US $ -63.06M 57.61M
United Therapeutics UTHR:US $ 140.5M 19.1M
Vertex Pharmaceuticals VRTX:US $ 718.03M 2.19M